top of page
Blue Abstract Background

Essilor

Stellest
1.0 and 2.0

Stellest Lens Details.jpg
Blue Abstract Background

Essilor Stellest 1.0

Stellest™ lenses are Essilor®’s game-changing innovation to slow down myopia progression in children.​* 

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day*

*Compared to single vision lenses, when worn by children at least 12 hours every day. Bao, J., Huang, Y., Li, X., Yang, A., Zhou, F., Wu, J., Wang, C., Li, Y., Lim, E.W., Spiegel, D.P., Drobe, B., Chen, H., 2022. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 140(5), 472–478. https://doi.org/10.1001/jamaophthalmol.2022.0401

1

H.A.L.T Technology

Highly Aspherical Lenslet Target or H.A.L.T employs a constellation of aspherical lenslets to slow down myopia progression.

2

11 Concentric Rings &
Retinal Defocus Signal

Features 11 concentric rings of micro-lenslets that create a specialized light signal in front of the retina to naturally slow down eye elongation.

3

Clear Vision 

Features a smooth, clear central zone for sharp everyday vision during school, reading, and sports.

Blue Abstract Background

Essilor Stellest 2.0

Essilor® Stellest® 2.0 lenses demonstrate greater efficacy in myopia management. ¹ ²

STELLEST_StillFrames_Frames3.jpg
Gradient Background

Stellest 2.0 Benefits

  • Higher power³, higher efficacy in managing myopia progression⁴ ⁵ 

  • Correct myopia​. Designed to provide sharp vision with your child's prescription⁶ ⁷ 

  • No compromises: Aesthetic and simple to wear 

UncutLens_WithProjectedShadow_STILL.tif

Essilor's Most Effective

Myopia Management Lenses

img11.jpg

In 2020, Essilor® unveiled the first generation of Essilor® Stellest® lenses, slowing myopia progression by 67% on average⁸ ⁹, helping millions of children worldwide. 

Building on the success of the previous generation​, Essilor® Stellest® 2.0 lenses provide higher strength, higher efficacy in managing myopia progression vs Essilor® Stellest® lenses (first generation). 

Blue Abstract Background

Why choose the Essilor Stellest 2.0 lenses for your child? 

Rayban_SideWithTechno_Still.tif

1

#1 Essilor®'s most efficacious myopia management spectacle lenses

With Essilor® Stellest® 2.0 lenses, eye growth in myopic children was 1.88 times slower than with the previous-generation¹⁰ ¹¹

2

H.A.L.T.¹²  MAX technology

Essilor® Stellest® 2.0 lenses provide twice the signal for slowing myopia progression¹³, delivering better results¹⁴ ¹⁵ vs the first generation of Essilor® Stellest® lenses. The enhanced efficacy of Essilor® Stellest® 2.0 lenses is supported by clinical trial results¹⁶

3

Correct and Manage Myopia

Designed to provide sharp vision with your child's prescription while also manage their myopia and control their myopic growth.

STEL_BOY_IMAGE_16x9.jpg
Green Gradient Circle

Can my child wear Essilor Stellest 2.0 lenses?

Our clinical results show that Essilor® Stellest 2.0 lenses are our most effective solution for managing myopia in children, including younger ones who may be at higher risk of progression .¹⁷

Contact our experience team to learn more about Stellest 2.0 

CONTACT

US

Tel. (+64)9 379 9157

Em. info@myopia.co.nz

VISIT

US

111 Parnell Road

Parnell, AUK 1052

Monday - Friday 10:00 - 17:30

Saturday & Sunday 10:00 - 16:00 

 

Disclaimer and references

1. Compared to Essilor® Stellest® first generation. 

2. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

3. Higher strength refers to the increased depth of volume of non-focused light in front of the retina - twice that of Essilor® Stellest® lenses by design - and is not associated with doubling of dioptric power of lenslets or efficacy. 

4.  Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children. 

5.  Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

6. No significant difference in distance BCVA between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses when looking through the central zone of the lens (Drobe B, et al. Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance. Invest Ophthalmol Vis Sci. 2025;66:2144) 

7. When looking through the peripheral aspherical lenslet portion of the lens, there was no significant difference between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses in high contrast distance visual acuity (VA), low contrast distance VA and low contrast near VA (EssilorLuxottica. Data on File. 2025 Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance.) 

8.  Compared to single vision lenses, when worn 12 hours per day every day for two consecutive years. 

9. Bao J, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA ophthalmology. 2022;140(5):472-8; ​ 

10. Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children. 

11. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

12. H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.​ 

13. Twice the signal refers to two (or more) times the depth of volume of non-focused light (by design) compared to that of Essilor® Stellest® lenses and is not associated with a doubling of lens power, lenslet power, or efficacy. 

14. Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children. 

15. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

16. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

17. Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9. 

bottom of page